The next thing in prognostic molecular markers: microRNA signatures of cancer

WM Grady, M Tewari - Gut, 2010 - gut.bmj.com
Cancer is known to be a consequence of the accumulation of mutations and epigenetic
alterations of oncogenes and tumour suppressor genes, which cooperate to cause a normal …

[HTML][HTML] Combination of hsa-miR-375 and hsa-miR-142-5p as a predictor for recurrence risk in gastric cancer patients following surgical resection

X Zhang, Z Yan, J Zhang, L Gong, W Li, J Cui, Y Liu… - Annals of oncology, 2011 - Elsevier
Background Recurrence is a major factor leading to treatment failure and death in gastric
cancer (GC) patients following surgical resection. Importantly, the prediction of recurrence is …

Gene expression profile for predicting survival in advanced-stage serous ovarian cancer across two independent datasets

K Yoshihara, A Tajima, T Yahata, S Kodama… - PloS one, 2010 - journals.plos.org
Background Advanced-stage ovarian cancer patients are generally treated with
platinum/taxane-based chemotherapy after primary debulking surgery. However, there is a …

Activation of Wnt/β-catenin signalling pathway induces chemoresistance to interferon-α/5-fluorouracil combination therapy for hepatocellular carcinoma

T Noda, H Nagano, I Takemasa, S Yoshioka… - British journal of …, 2009 - nature.com
Type I IFN receptor type 2 (IFNAR2) expression correlates significantly with clinical response
to interferon (IFN)-α/5-fluorouracil (5-FU) combination therapy for hepatocellular carcinoma …

UBXD proteins: a family of proteins with diverse functions in cancer

K Rezvani - International journal of molecular sciences, 2016 - mdpi.com
The UBXD family is a diverse group of UBX (ubiquitin-regulatory X) domain-containing
proteins in mammalian cells. Members of this family contain a UBX domain typically located …

Possible involvement of CCT5, RGS3, and YKT6 genes up-regulated in p53-mutated tumors in resistance to docetaxel in human breast cancers

A Ooe, K Kato, S Noguchi - Breast cancer research and treatment, 2007 - Springer
Background Present study was aimed to investigate the relationship of p53 mutation status
with response to docetaxel in breast cancers. In addition, attempts were made to identify the …

Identification of hsa-miR-335 as a prognostic signature in gastric cancer

Z Yan, Y Xiong, W Xu, J Gao, Y Cheng, Z Wang… - Plos one, 2012 - journals.plos.org
Background Gastric cancer (GC) is one of the most common malignancy and primary cause
of death in Chinese cancer patients. Recurrence is a major factor leading to treatment failure …

A liquid biopsy signature for predicting early recurrence in patients with gastric cancer

K Okuno, S Watanabe, S Roy, M Kanda… - British Journal of …, 2023 - nature.com
Background Gastric cancer (GC) patients who experience recurrence within the first year
following surgery (early recurrence [ER]) exhibit worse prognosis. Herein, we established a …

Integrative approach for differentially overexpressed genes in gastric cancer by combining large-scale gene expression profiling and network analysis

A Takeno, I Takemasa, Y Doki, M Yamasaki… - British journal of …, 2008 - nature.com
Gene expression profiling is a valuable tool for identifying differentially expressed genes in
studies of disease subtype and patient outcome for various cancers. However, it remains …

Up-regulation of CLDN1 in gastric cancer is correlated with reduced survival

LL Eftang, Y Esbensen, TM Tannæs, GP Blom… - BMC cancer, 2013 - Springer
Background The genetic changes in gastric adenocarcinoma are extremely complex and
reliable tumor markers have not yet been identified. There are also remarkable geographical …